Collin R. Barnum

Collin R. Barnum

Auto-generated profile, based on publicly available information

Collin R. Barnum

Biochemistry, Molecular, Cellular and Developmental Biology Graduate Group, University of California, Davis, CA 95616, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SSSasilada Sirirungruang
Sasilada Sirirungruang
CBCollin R. Barnum
Collin R. Barnum
STSophia N. Tang
Sophia N. Tang
PSPatrick Shih
Patrick Shih
This article highlights previous and prospective uses for plant glycosyltransferases in generating and diversifying bioactive glycosides, with implications in drug discovery applications.

1 January 2020 in BioDesign Research
Verified
Journal Article
Open access
PDF file
MTMitchell G. Thompson
Mitchell G. Thompson
WMWilliam M. Moore
William M. Moore
NHNiklas F.C. Hummel
Niklas F.C. Hummel
APAllison N. Pearson
Allison N. Pearson
CBCollin R. Barnum
Collin R. Barnum
PSPatrick Shih
Patrick Shih
Agrobacterium tumefaciens is an important tool in plant biotechnology due to its natural ability to transfer DNA into the genomes of host plants. Genetic manipulations of A. tumefaciens have yielded considerable advances in increasing transformational efficiency in a number of plant species and cultivars. Moreover, there is overwhelming evidence that modulating the expression of various mediators of A. tumefaciens virulence can lead to more successful plant transformation; thus, the application of synthetic biology to enable targeted engineering of the bacterium may enable new opportunities for advancing plant biotechnology. In this review, we highlight engineering targets in both A. tumefaciens and plant hosts that could be exploited more effectively through precision genetic control to generate high-quality transformation events in a wider range of host plants. We then further discuss the current state of A. tumefaciens and plant engineering with regard to plant transformation and describe how future work may incorporate a rigorous synthetic biology approach to tailor strains of A. tumefaciens used in plant transformation.

8 December 2023 in Biology
Verified
Journal Article
Open access
PDF file
STSophia N. Tang
Sophia N. Tang
CBCollin R. Barnum
Collin R. Barnum
MSMatthew J. Szarzanowicz
Matthew J. Szarzanowicz
SSSasilada Sirirungruang
Sasilada Sirirungruang
PSPatrick Shih
Patrick Shih
Plants possess an innate ability to generate vast amounts of sugar and produce a range of sugar-derived compounds that can be utilized for applications in industry, health, and agriculture. Nucleotide sugars lie at the unique intersection of primary and specialized metabolism, enabling the biosynthesis of numerous molecules ranging from small glycosides to complex polysaccharides. Plants are tolerant to perturbations to their balance of nucleotide sugars, allowing for the overproduction of endogenous nucleotide sugars to push flux towards a particular product without necessitating the re-engineering of upstream pathways. Pathways to produce even non-native nucleotide sugars may be introduced to synthesize entirely novel products. Heterologously expressed glycosyltransferases capable of unique sugar chemistries can further widen the synthetic repertoire of a plant, and transporters can increase the amount of nucleotide sugars available to glycosyltransferases. In this opinion piece, we examine recent successes and potential future uses of engineered nucleotide sugar biosynthetic, transport, and utilization pathways to improve the production of target compounds. Additionally, we highlight current efforts to engineer glycosyltransferases. Ultimately, the robust nature of plant sugar biochemistry renders plants a powerful chassis for the production of target glycoconjugates and glycans.